These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 10807196)

  • 1. Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain. The ERASE-2 Study Group.
    Puig T; Pérez-Olmeda M; Rubio A; Ruiz L; Briones C; Franco JM; Gómez-Cano M; Stuyver L; Zamora L; Alvarez C; Leal M; Clotet B; Soriano V
    AIDS; 2000 Apr; 14(6):727-32. PubMed ID: 10807196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study.
    Salomon H; Wainberg MA; Brenner B; Quan Y; Rouleau D; Coté P; LeBlanc R; Lefebvre E; Spira B; Tsoukas C; Sekaly RP; Conway B; Mayers D; Routy JP
    AIDS; 2000 Jan; 14(2):F17-23. PubMed ID: 10708278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.
    Gómez-Cano M; Rubio A; Puig T; Pérez-Olmeda M; Ruiz L; Soriano V; Pineda JA; Zamora L; Xaus N; Clotet B; Leal M
    AIDS; 1998 Jun; 12(9):1015-20. PubMed ID: 9662197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals.
    Balotta C; Berlusconi A; Pan A; Violin M; Riva C; Colombo MC; Gori A; Papagno L; Corvasce S; Mazzucchelli R; Facchi G; Velleca R; Saporetti G; Galli M; Rusconi S; Moroni M
    Antivir Ther; 2000 Mar; 5(1):7-14. PubMed ID: 10846586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the rate of genotypic resistance to antiretroviral drugs in Spain.
    Gallego O; Ruiz L; Vallejo A; Ferrer E; Rubio A; Clotet B; Leal M; Soriano V;
    AIDS; 2001 Sep; 15(14):1894-6. PubMed ID: 11579258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary HIV-1 drug resistance in Spain before and after the introduction of protease inhibitors.
    Pérez-Olmeda M; Del Romero J; Rubio A; Ruiz L; Rodríguez C; Leal M; Clotet B; Soriano V
    J Med Virol; 2001 Feb; 63(2):85-7. PubMed ID: 11170042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individuals.
    Simon V; Vanderhoeven J; Hurley A; Ramratnam B; Louie M; Dawson K; Parkin N; Boden D; Markowitz M
    AIDS; 2002 Jul; 16(11):1511-9. PubMed ID: 12131189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance in patients experiencing early virological failure under a triple combination including indinavir.
    Gallego O; de Mendoza C; Pérez-Elías MJ; Guardiola JM; Pedreira J; Dalmau D; Gónzalez J; Moreno A; Arribas JR; Rubio A; García-Arata I; Leal M; Domingo P; Soriano V
    AIDS; 2001 Sep; 15(13):1701-6. PubMed ID: 11546946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of HIV-1 drug resistance mutations among Spanish prison inmates.
    García-Guerrero J; Sáiz de la Hoya P; Portilla J; Marco A; Sánchez-Payá J; Moreno S;
    Eur J Clin Microbiol Infect Dis; 2006 Nov; 25(11):695-701. PubMed ID: 17043836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of drug resistance mutations in Spain among both naive and pretreated patients.
    Soriano V
    Antivir Ther; 1999; 4 Suppl 3():57-63. PubMed ID: 16021872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 drug resistance in newly infected individuals.
    Boden D; Hurley A; Zhang L; Cao Y; Guo Y; Jones E; Tsay J; Ip J; Farthing C; Limoli K; Parkin N; Markowitz M
    JAMA; 1999 Sep 22-29; 282(12):1135-41. PubMed ID: 10501116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in HIV-1 pol gene associated with reduced sensitivity to antiretroviral drugs in treatment-naive patients.
    Birk M; Sönnerborg A
    AIDS; 1998 Dec; 12(18):2369-75. PubMed ID: 9875574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of drug resistance mutations among HIV-1-infected Tunisian subjects failing antiretroviral therapy.
    Jlizi A; Ben Ammar El Gaaied A; Slim A; Tebourski F; Ben Mamou M; Ben Chaabane T; Letaief-Omezzine A; Chakroun M; Garbouj M; Ben Rejeb S
    Arch Virol; 2008; 153(6):1103-8. PubMed ID: 18483694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients. Swiss HIV Cohort Study.
    Khanna N; Klimkait T; Schiffer V; Irigoyen J; Telenti A; Hirschel B; Battegay M
    AIDS; 2000 May; 14(7):791-9. PubMed ID: 10839586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy.
    Servais J; Lambert C; Fontaine E; Plesséria JM; Robert I; Arendt V; Staub T; Schneider F; Hemmer R; Burtonboy G; Schmit JC
    J Clin Microbiol; 2001 Feb; 39(2):454-9. PubMed ID: 11158089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reverse transcriptase codon 69 insertion is observed in nucleoside reverse transcriptase inhibitor-experienced HIV-1-infected individuals, including those without prior or concurrent zidovudine therapy.
    Ross L; Johnson M; Graham N; Shaefer M; St Clair M
    J Hum Virol; 1999; 2(5):290-5. PubMed ID: 10551735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study.
    Descamps D; Calvez V; Izopet J; Buffet-Janvresse C; Schmuck A; Colson P; Ruffault A; Maillard A; Masquelier B; Cottalorda J; Harzic M; Brun-Vézinet F; Costagliola D;
    AIDS; 2001 Sep; 15(14):1777-82. PubMed ID: 11579238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary drug resistance in antiretroviral-naïve injection drug users.
    Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
    Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid.
    Briones C; Pérez-Olmeda M; Rodríguez C; del Romero J; Hertogs K; Soriano V
    J Acquir Immune Defic Syndr; 2001 Feb; 26(2):145-50. PubMed ID: 11242181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evolution of HIV resistance mutations in the Valme referral center].
    Nogales MC; Castro C; Martín-Mazuelos E
    Enferm Infecc Microbiol Clin; 2007 Feb; 25(2):159. PubMed ID: 17288915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.